Panel

Name: CRISPR: Patent Disputes and Licensing Challenges
Start: 2023-01-25T17:00:00-05:00
End: 2023-01-25T18:30:00-05:00

Views Navigation

Event Views Navigation

List

Today

Select date.

Latest Past Events

Mar 22 2024

March 22, 2024 @ 8:00 am - March 23, 2024 @ 5:00 pm EDT

NECann

The New England Cannabis Conference in Boston is the 2nd largest B2B cannabis conference in the world. The 2024 conference will feature over 350 exhibitors, five full programming tracks, multiple…

Jan 25 2023

January 25, 2023 @ 5:00 pm - 6:30 pm EST

CRISPR: Patent Disputes and Licensing Challenges

Counsel Gretchen Temeles of Skip Intro Advisors' partner agency Feldman Legal Advisors will be attending.

Skip Intro Advisors

Advisors
Partners
Events
Blog
Newsroom
About
Search for

facebook
twitter
instagram
linkedin
pinterest

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settings ACCEPT

Privacy & Cookies Policy

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.

Non-necessary

Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.

SAVE & ACCEPT